# Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/advancements-in-clinical-aspects-of-targeted-therapy-and-immunotherapy-in-breast/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Feng Ye,Saikat Dewanjee,Yuehua Li,Niraj Kumar Jha,Zhe‐Sheng Chen,Ankush Kumar,vishakha vishakha,Tapan Behl,Saurabh Kumar Jha,Hailin Tang |
| Citations | 542 |
| DOI | 10.1186/s12943-023-01805-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://molecular-cancer.biomedcentral.com/counter/pdf/10.1186/s12943-023-01805-y |
| OpenAlex ID | https://openalex.org/W4383369517 |
| PMID | 37415164 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Hailin Tang](https://scholariq.org/researchers/hailin-tang/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.